Taiwan FDA registration ed25c15c29e1f934ecba36d37e961191
Unified drug self-test pregnancy test pen
TW: 統一藥品自我檢測驗孕筆
Taiwan·Risk Class 2·Formosa Biomedical Technology Co., Ltd. Yilan Factory;; Unipharmacy Co., Ltd·Registered Dec 31, 2009 – Jan 10, 2027ActiveRegistration details
- Analysis ID
- ed25c15c29e1f934ecba36d37e961191
- Customs Code
- DHY00500302207
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- PRESIDENT PHARMACEUTICAL CORPORATION
Product details
- Intended Use
- Human chorionic gonadotropin (HCG) was detected in urine using rapid immunochromatography.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1155 Human chorionic gonadotropin testing system
- Import Information
- Domestic
Dates and status
- Registration Date
- Dec 31, 2009
- Expiry Date
- Jan 10, 2027
About this record
Access comprehensive regulatory information for Unified drug self-test pregnancy test pen in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ed25c15c29e1f934ecba36d37e961191 and manufactured by Formosa Biomedical Technology Co., Ltd. Yilan Factory;; Unipharmacy Co., Ltd. The authorized representative in Taiwan is PRESIDENT PHARMACEUTICAL CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices